Potency of HI-6 to Reactivate Cyclosarin, Soman and Tabun Inhibited Acetylcholinesterase - In Vivo Study

被引:0
|
作者
Karasova, Jana Zdarova [1 ]
Kassa, Jiri [1 ]
Pohanka, Miroslav [2 ]
Musilek, Kamil [1 ]
Kuca, Kamil [1 ,2 ]
机构
[1] Univ Def, Dept Toxicol, Fac Mil Hlth Sci, Hradec Kralove 50001, Czech Republic
[2] Univ Def, Ctr Adv Studies, Fac Mil Hlth Sci, Hradec Kralove 50001, Czech Republic
关键词
HI-6; Tabun; Cyclosarin; Soman; Broad-spectrum; Oxime; BRAIN-BARRIER PENETRATION; PYRIDINIUM OXIMES; EFFICACY; ORGANOPHOSPHORUS; BLOOD; HPLC; ANTIDOTES; RATS;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Broad-spectrum reactivator is an oxime which is able to reactivate acetylcholinesterase (AChE) inhibited by many kinds of organophosphate inhibitors of AChE, mainly nerve agents. There are many AChE reactivators (oximes) as suitable candidates for the broad-spectrum reactivator. Among them, oxime HI-6 is considered as number one, and due to its properties, it is recommended by many armies to be introduced as universal antidotal mean. In this study, we wanted to summarize that the designation "broad spectrum" is prerogative. For this purpose, in vivo evaluation of therapeutical dose of HI-6 (39.0 mg/kg) was performed. Soman, cyclosarin and tabun were used as the typical members of nerve agent family. According to the obtained results, oxime HI-6 did not sufficiently reactivate tabun-inhibited AChE. Brain AChE was also only partially protected. Based on these results, it seems that HI-6 in therapeutical dose has effect only in peripheral compartment.
引用
收藏
页码:516 / 520
页数:5
相关论文
共 50 条
  • [31] Potency of new structurally different oximes to reactivate cyclosarin inhibited-human brain acetylcholinesterases
    Kuca, Kamil
    Cabal, Jiri
    Jun, Daniel
    Bajgar, Jiri
    Kassa, Jiri
    Fusek, Josef
    TOXICOLOGY, 2007, 233 (1-3) : 231 - 232
  • [32] EFFECTS OF HI-6 ON BRAIN NEURONAL RNA AND ACETYLCHOLINESTERASE - METABOLIC RESPONSES DURING ACUTE SOMAN INTOXICATION
    DOEBLER, JA
    WALL, TJ
    MARTIN, LJ
    SHIH, TM
    ANTHONY, A
    TOXICOLOGY, 1984, 33 (3-4) : 311 - 322
  • [33] In vitro potency of H oximes (HI-6, HLo-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase
    Kuca, Kamil
    Cabal, Jiri
    Kassa, Jiri
    Jun, Daniel
    Hrabinova, Martina
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2006, 69 (15): : 1431 - 1440
  • [34] FAILURE OF TOXOGONIN TO REACTIVATE SOMAN-INHIBITED BRAIN ACETYLCHOLINESTERASE IN MONKEYS AND REGENERATION OF ENZYME
    FILBERT, MG
    FLEISHER, JH
    LOCHNER, MA
    BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 284 (01) : 164 - &
  • [35] DIFFERENTIAL REACTIVATION BY HI-6 IN-VIVO OF PARAOXON-INHIBITED RAT-BRAIN ACETYLCHOLINESTERASE MOLECULAR-FORMS
    BAJGAR, J
    MICHALEK, H
    BISSO, GM
    NEUROCHEMISTRY INTERNATIONAL, 1995, 26 (04) : 347 - 350
  • [36] Efficacy of structural homoloques and isomers of pralidoxime in reactivation of immobilised acetylcholinesterase inhibited with sarin, cyclosarin and soman
    Hoskovcova, Monika
    Halamek, Emil
    Kobliha, Zbynek
    NEUROENDOCRINOLOGY LETTERS, 2009, 30 : 152 - 155
  • [37] In vitro reactivation potency of acetylcholinesterase reactivators — K074 and K075 — to reactivate tabun-inhibited human brain cholinesterases
    Kamil Kuca
    Jiri Cabal
    Daniel Jun
    Kamil Musilek
    Neurotoxicity Research, 2007, 11
  • [38] In vitro reactivation potency of acetylcholinesterase reactivators -: K074 and K075-: to reactivate tabun-inhibited human brain cholinesterases
    Kuca, Kamil
    Cabal, Jiri
    Jun, Daniel
    Musilek, Kamil
    NEUROTOXICITY RESEARCH, 2007, 11 (02) : 101 - 106
  • [39] Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro
    Jun, D.
    Musilova, L.
    Kuca, K.
    Kassa, J.
    Bajgar, J.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2008, 175 (1-3) : 421 - 424
  • [40] THERAPEUTIC EFFICACY OF HI-6 IN SOMAN-POISONED MARMOSET MONKEYS
    VANHELDEN, HPM
    VANDERWIEL, HJ
    DELANGE, J
    BUSKER, RW
    MELCHERS, BPC
    WOLTHUIS, OL
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 115 (01) : 50 - 56